Jonathan Beall, PhD, is an Assistant Professor of Biostatistics in the Department of Public Health Sciences (DPHS) at the Medical University of South Carolina (MUSC) and Senior Biostatistician with the Data Coordination Unit (DCU). He received his BA in Economics and BS in Mathematics from Mercer University (2016) and his PhD in Biostatistics from MUSC (2021). As a faculty member of the DCU, Dr. Beall is involved in the design, conduct and analysis of multi-center, randomized clinical trials implemented in the SIREN (Strategies to Innovate Emergency Care Clinical Trials) and StrokeNet clinical trials networks, including: C3PO (Clinical Trial of COVID-19 Convalescent Plasma of Outpatients), BOOST-3 (Brain Oxygen Optimization in Severe TBI Phase-3), CAPTIVA (Comparison of Anti-coagulation and Anti-platelet Therapies for Intracranial Vascular Atherostenosis), RHAPSODY-II (Recombinant variant of Human Activated Protein C (APC), in combination with tPA in acute hemispheric ischemic stroke), and HOBIT (Hyperbaric Oxygen Brain Injury Treatment Trial). His research interests include adaptive and Bayesian clinical trial designs, Bayesian methodologies, and latent variable methods. Dr. Beall actively serves on Data and Safety Monitoring Boards (DSMBs), grant review panels, as a reviewer for numerous journals, and professional organizations through internal committee membership (Society for Clinical Trials and South Carolina Chapter of the American Statistical Association).